Dr Hannah Rose Wardill

Dr. Hannah Rose Wardill is the founder of the Supportive Oncology Research Group at the University of Adelaide, a pioneering initiative aimed at improving the quality of life for those affected by cancer. The group focuses on innovative research into the causes, detection, prediction, and prevention of gastrointestinal issues, particularly diarrhoea related to cancer treatments. With a solid background in gastrointestinal physiology and mucosal immunology, Dr. Wardill's team has conducted significant studies, including randomized clinical trials exploring Faecal Microbiota Transfer for ulcerative colitis.

Informed by global experience, including a transformative postdoctoral training in supportive cancer care in the Netherlands, the group is committed to understanding the gut microbiome's impact on a range of side effects arising from cancer therapies, such as cognitive impairment and pain. Their mission is to provide essential evidence-based solutions ensuring that cancer survivors in Australia live not just longer, but healthier lives, free from undue physical and psychosocial burdens of cancer treatment.